MDxHealth holder Lytton reports 19.5% stake
MDxHealth SA shareholders Laurence W. Lytton and the Lytton-Kambara Foundation report beneficial ownership of 18,558,988 and 11,583,098 Ordinary Shares, respectively.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MDxHealth SA shareholders Laurence W. Lytton and the Lytton-Kambara Foundation report beneficial ownership of 18,558,988 and 11,583,098 Ordinary Shares, respectively. These positions represent 19.5% and 12.1% of the Ordinary Shares outstanding, based on 95,417,382 shares outstanding as of August 13, 2026.
Lytton reports 3,933,448 shares with sole voting and dispositive power and 14,625,540 shares with shared voting and dispositive power. The Foundation reports 11,583,098 shares with shared voting and dispositive power and no sole voting or dispositive power. Lytton and the Foundation have agreed to a joint filing of this Schedule 13G/A.
Key Figures
Key Terms
beneficially owned financial
Sole Voting Power financial
Schedule 13D or 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of MDXH does Laurence W. Lytton report owning in this Schedule 13G/A?
Are Laurence W. Lytton and the Lytton-Kambara Foundation filing jointly for MDXH?
AI-generated analysis. How Rhea-AI works. Not financial advice.